CDKN2B and neoplasm: Current evidence shows that although these two members of INK4 family have significantly overlapping roles, there are p15INK4b-unique tumor suppressing function that are illustrated by more aggressive tumors with CDKN2B deletion especially in certain signaling context (e.g. oncogenic RAS).